APPLICATION
ANDA213570
TYPE
ANDA
ORIGINAL APPROVAL
2022-09-26
LATEST ACTION
2022-09-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
BREXPIPRAZOLEDiscontinued
BREXPIPRAZOLE 3MG · TABLET · ORAL
BREXPIPRAZOLEDiscontinued
BREXPIPRAZOLE 1MG · TABLET · ORAL
BREXPIPRAZOLEDiscontinued
BREXPIPRAZOLE 0.25MG · TABLET · ORAL
BREXPIPRAZOLEDiscontinued
BREXPIPRAZOLE 4MG · TABLET · ORAL
BREXPIPRAZOLEDiscontinued
BREXPIPRAZOLE 2MG · TABLET · ORAL
BREXPIPRAZOLEDiscontinued
BREXPIPRAZOLE 0.5MG · TABLET · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.